167 related articles for article (PubMed ID: 26137098)
1. Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development.
Ke XX; Zhang D; Zhao H; Hu R; Dong Z; Yang R; Zhu S; Xia Q; Ding HF; Cui H
Oncol Lett; 2015 Jun; 9(6):2507-2514. PubMed ID: 26137098
[TBL] [Abstract][Full Text] [Related]
2. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development.
Alam G; Cui H; Shi H; Yang L; Ding J; Mao L; Maltese WA; Ding HF
Am J Pathol; 2009 Aug; 175(2):856-66. PubMed ID: 19608868
[TBL] [Abstract][Full Text] [Related]
3. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
5. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA
Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574
[TBL] [Abstract][Full Text] [Related]
6. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
[TBL] [Abstract][Full Text] [Related]
7. A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma.
Gifford AJ; Murray J; Fletcher JI; Marshall GM; Norris MD; Haber M
Curr Protoc; 2021 Nov; 1(11):e310. PubMed ID: 34826366
[TBL] [Abstract][Full Text] [Related]
8. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ret-, p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase-immunoreactivity by undifferentiated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut.
Young HM; Ciampoli D; Hsuan J; Canty AJ
Dev Dyn; 1999 Oct; 216(2):137-52. PubMed ID: 10536054
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma models for insights into tumorigenesis and new therapies.
Kiyonari S; Kadomatsu K
Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
[TBL] [Abstract][Full Text] [Related]
11. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
12. PHOX2B is a suppressor of neuroblastoma metastasis.
Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
[TBL] [Abstract][Full Text] [Related]
13. The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma.
Parkinson LM; Gillen SL; Woods LM; Chaytor L; Marcos D; Ali FR; Carroll JS; Philpott A
Front Cell Dev Biol; 2022; 10():942579. PubMed ID: 36263020
[TBL] [Abstract][Full Text] [Related]
14. The role of β-catenin and paired-like homeobox 2B (PHOX2B) expression in neuroblastoma patients; predictive and prognostic value.
El-Shazly SS; Hassan NM; Abdellateif MS; El Taweel MA; Abd-Elwahab N; Ebeid EN
Exp Mol Pathol; 2019 Oct; 110():104272. PubMed ID: 31220430
[TBL] [Abstract][Full Text] [Related]
15. PHOX2B as a Reliable Marker for Neuroblastoma in Tissue and Cytology Specimens.
Ma Y; Feng J; Zhao J; Ding D; Tian F; Chen L; Zheng J; Xiao X
J Neuropathol Exp Neurol; 2021 Dec; 80(12):1108-1116. PubMed ID: 34965292
[TBL] [Abstract][Full Text] [Related]
16. RT-qPCR for
Grèze V; Kanold J; Chambon F; Halle P; Gremeau AS; Rives N; Rouel N; Pereira B; Tchirkov A; Brugnon F
Oncol Lett; 2017 Jul; 14(1):860-866. PubMed ID: 28693243
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
Vivancos Stalin L; Gualandi M; Schulte JH; Renella R; Shakhova O; Mühlethaler-Mottet A
Front Oncol; 2019; 9():275. PubMed ID: 31058082
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
[TBL] [Abstract][Full Text] [Related]
19. Generation of conditional ALK F1174L mutant mouse models for the study of neuroblastoma pathogenesis.
Ono S; Saito T; Terui K; Yoshida H; Enomoto H
Genesis; 2019 Oct; 57(10):e23323. PubMed ID: 31218818
[TBL] [Abstract][Full Text] [Related]
20. The MYCN oncogene and differentiation in neuroblastoma.
Westermark UK; Wilhelm M; Frenzel A; Henriksson MA
Semin Cancer Biol; 2011 Oct; 21(4):256-66. PubMed ID: 21849159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
